Circulation, Vol 78, 1200-1209, Copyright © 1988 by American Heart Association
AL McGinn, RF Wilson, MT Olivari, DC Homans and CW White
Cardiac transplantation is frequently associated with accelerated coronary
atherosclerosis and immune-mediated microvascular injury. To determine if
orthotopic cardiac transplantation impairs the capacity of the coronary
vasculature to vasodilate and conduct hyperemic blood flow, maximal
coronary vasodilator reserve was measured in 25 cardiac allograft
recipients with no evidence of rejection 6-57 months after transplantation
and in 20 normal subjects. Left ventricular wall thickness was assessed
echocardiographically, and epicardial coronary anatomy was evaluated by
quantitative coronary angiography. Coronary vasodilator reserve (CVDR) was
measured in all patients with a coronary Doppler catheter and a maximally
vasodilating dose of intracoronary papaverine. CVDR measured in the
transplant recipients with normal coronary arteries, left ventricular
function, and wall thickness (5.0 +/- 0.3 [mean +/- SEM] peak/resting
velocity; range, 3.8-7.3; n = 16) was not different from that of normal
subjects (4.8 +/- 0.2; range, 3.7- 8.3). CVDR in the five cardiac allograft
recipients with diffuse coronary atherosclerosis producing 30 +/- 5%
narrowing (range, 25-38%) of epicardial vessel diameter also was normal
(5.1 +/- 0.3; range, 4.3- 6.2; n = 5). The CVDR was reduced, however, in
two of the four cardiac allograft recipients with left ventricular
hypertrophy. In the only transplant recipient in whom a regional wall
motion abnormality was present, CVDR was abnormal in the vascular
distribution of the hypokinetic wall segment (1.8) but was normal in the
artery that supplied normally functioning myocardium (4.0). These findings
demonstrate that in the absence of allograft rejection, acquired left
ventricular hypertrophy, and regional wall motion abnormalities, coronary
vasodilator reserve is normal after orthotopic human cardiac
transplantation.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Coronary vasodilator reserve after human orthotopic cardiac transplantation
Department of Medicine, University of Minnesota, Minneapolis.
This article has been cited by other articles:
![]() |
O. M. Muehling, N. M. Wilke, P. Panse, M. Jerosch-Herold, B. V. Wilson, R. F. Wilson, and L. W. Miller Reduced myocardial perfusion reserve and transmural perfusiongradient in heart transplant arteriopathyassessed by magnetic resonance imaging J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1054 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nitenberg, S. Ledoux, P. Valensi, R. Sachs, J.-R. Attali, and I. Antony Impairment of Coronary Microvascular Dilation in Response to Cold Pressor-Induced Sympathetic Stimulation in Type 2 Diabetic Patients With Abnormal Stress Thallium Imaging Diabetes, May 1, 2001; 50(5): 1180 - 1185. [Abstract] [Full Text] |
||||
![]() |
T. L. Wolford, T. J. Donohue, R. G. Bach, J. H. Drury, E. A. Caracciolo, M. J. Kern, and L. W. Miller Heterogeneity of Coronary Flow Reserve in the Examination of Multiple Individual Allograft Coronary Arteries Circulation, February 9, 1999; 99(5): 626 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Kofoed, J. Czernin, J. Johnson, J. Kobashigawa, M. E. Phelps, H. Laks, and H. R. Schelbert Effects of Cardiac Allograft Vasculopathy on Myocardial Blood Flow, Vasodilatory Capacity, and Coronary Vasomotion Circulation, February 4, 1997; 95(3): 600 - 606. [Abstract] [Full Text] |
||||
![]() |
G. Vassalli, A. Gallino, W. Kiowski, Z. Jiang, M. Turina, and O. M. Hess Reduced Coronary Flow Reserve During Exercise in Cardiac Transplant Recipients Circulation, February 4, 1997; 95(3): 607 - 613. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |